Supplementary Material - Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Published: 29 November 2022| Version 1 | DOI: 10.17632/vnfbmxpx22.1
Contributors:
Lisa Beck, Thomas Bieber, Stephan Weidinger, Marie Tauber, Hidehisa Saeki, Alan Irvine, Lawrence Eichenfield, Thomas Werfel , Petra Arlert, Li J, Mads Røpke, Amy Paller

Description

Supplementary Information to accompany and support the manuscript: Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.

Files

Categories

Dermatology, Microbiome, Clinical Trial, Atopic Dermatitis

Funding

LEO Pharma

Licence